Clinical study - Recherches "plusieurs pathologies"

ALCINA-4 (IC 2020-11)
Recherches "plusieurs pathologies"
Ouvert depuis le: 05.25.2024
Site: Paris
Ouvert depuis le: 05.18.2022
Site: Saint-Cloud
Public cible
Adulte
Analysis of Circulating Tumor mArkers in Blood 4 - ALCINA 4
Description de l'essai
Multi-cohort exploratory prospective study. Participation in the ALCINA 4 study does not change the standard management of the patient, including the treatments administered. A sampling schedule will be set up for each cohort.;Depending on the clinical context studied and the biomarkers studied and/or sought, the timing of blood samples will vary between cohorts. There may be up to 4 samples taken per patient for up to 12 or 18 months. If a specific tumor sample is required, it will be collected only once during the Study.
Vignette
FRANCOIS-CLEMENT BIDARD
Investigateur principal
Vignette
FRANCOIS-CLEMENT BIDARD
Investigateur principal